-
Recent Posts
- ITC decision reversed as Chamberlain disavowed openers lacking infrared detectors
- DC grant of SJ of no literal or DOE infringement affirmed
- Appeal of IPR decision dismissed as litigation settled and “substantial risk of future infringement” not shown
- DC section 101 ineligibility decision reversed since the “the claimed invention is also directed to a non-abstract improvement”
- Remanded IPR decision reversed and vacated as “supported by…faulty reasoning”
Recent Comments
Categories
- America Invents Act
- Analgous Art
- Anticipation (35 USC 102)
- Antitrust
- Appeal
- Arbitration
- Article III disputes
- Assignment / Ownership
- Attorney's Fees
- Bankruptcy
- Best mode
- Biosimilars
- Business methods
- Certificate of Correction
- Claim
- Claim Construction
- Claim Differentiation
- Claim Preclusion
- Claim Vitiation
- Collateral estoppel
- Conception and Reduction to Practice
- Contributory Infringement
- Copyright
- Covered Business Method Reviews
- Damages
- Derivation of Invention
- Design Patents
- Diligence
- Disclaimers
- Discovery
- Doctrine of equivalents
- Double Patenting
- Enablement
- Equitable estoppel
- Exhaustion and Repair
- Experimental Use
- Expert Testimony
- False Marking
- Functional limitations
- Generics / ANDA
- Importation
- Indefiniteness
- Inducement to Infringe
- Inequitable Conduct
- Infringement
- Inherency
- Injunction
- Inter Parties Review (IPR)
- Interference
- International Trade Commission
- Inventorship
- IPR
- Issue Preclusion
- Jurisdiction
- Laches
- Licensing
- Lost Profits
- Malpractice
- Means-plus-function
- Method claims
- Negative Limitations
- Obviousness
- Obviousness-Teaching Away
- On-Sale Bar
- Patent Eligibility (101)
- Patent Exhaustion
- Patent Marking
- Patent Prosecution
- Patent Term Adjustment (PTA)
- Patent Term Extension
- Patentability
- Post-grant review
- Preamble
- Priority
- Privilege
- Procedural Issues
- Product-by-Process
- Prosecution History Estoppel
- Public Accessibility
- Public Use
- Reexamination
- Reissue
- Royalties
- Section 101 (see also Patentability)
- Software
- Summary Judgment
- Trade Dress
- Trade Secret
- Trademarks
- U.S. Supreme Court
- Uncategorized
- Unenforceability
- Unjust enrichment
- Utility
- Venue
- Wherein
- Willfullness
- Written description
Archives
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
- June 2016
- May 2016
- April 2016
- March 2016
- February 2016
- January 2016
- December 2015
- November 2015
- October 2015
- September 2015
- August 2015
- July 2015
- June 2015
- May 2015
- April 2015
- March 2015
- February 2015
- January 2015
- December 2014
- November 2014
- October 2014
- September 2014
- August 2014
- July 2014
- June 2014
- May 2014
- April 2014
- March 2014
- February 2014
- January 2014
- December 2013
- November 2013
- October 2013
- September 2013
- August 2013
- July 2013
- June 2013
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- July 2011
- February 2011
- January 2011
Meta
- America Invents Act Anticipation (35 USC 102) Appeal Article III disputes Assignment / Ownership Attorney's Fees Claim Construction Claim Differentiation Collateral estoppel Damages Doctrine of equivalents Generics / ANDA Indefiniteness Inducement to Infringe Infringement Injunction Inter Parties Review (IPR) Inventorship IPR Means-plus-function Obviousness Obviousness-Teaching Away Patentability Prosecution History Estoppel Reexamination Software Trademarks Uncategorized Willfullness Written description
Copyright Notice
© Patrick J. Halloran, Ph.D., J.D. and lifescienceip.wordpress.com, [2011-2017]. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Patrick J. Halloran, Ph.D., J.D. and lifescienceip.wordpress.com with appropriate and specific direction to the original content.
Category Archives: Inducement to Infringe
Enplas Display Device Corp. et al. v. Seoul Semiconductor Company, Ltd.
Docket Nos. 2016-2599 NEWMAN, HUGHES, STOLL Nov. 19, 2018 Brief summary: DC findings of no anticipation affirmed; damages award vacated (e.g., “damages calculated by applying a royalty rate to sales of non-accused lenses cannot support a jury’s verdict on damages”). … Continue reading
AIDS Healthcare Foundation, Inc. v. Gilead Sciences, Inc. et al.
Docket No. 2016-2475 MOORE, REYNA, TARANTO May 11, 2018 Brief summary: DC dismissal of AHF’s request for DJ for not relating to a current “substantial controversy” affirmed. Summary: AHF appealed DC dismissal of its request for a declaratory judgment (DJ) … Continue reading
Vanda Pharm. Inc. v. West-Ward Pharm. Int. Ltd. et al.
Docket No. 2016-2707, -2708 PROST, LOURIE, HUGHES April 13, 2018 Brief summary: DC finding of infringement of later-issued OB patent by amended ANDA, and that method of treatment claims are patentable under § 101 affirmed. Summary: WW appealed DC holding … Continue reading
Nalco Company v. Chem-Med, LLC et al. (24 other parties)
Docket No. 2017-1036 MOORE, SCHALL, O’MALLEY February 27, 2018 Brief summary: DC dismissal of Nalco’s complaint for failing to properly allege infringement reversed and remanded since “[t]he ‘purpose of a motion to dismiss is to test the sufficiency of the … Continue reading
Liqwd, Inc., Olaplex LLC v. L’Oreal et al.
Docket No. 2017-2295 DYK, REYNA, TARANTO January 16, 2018 Non-precedential Brief summary: DC decision denying PI vacated and remanded as based on erroneous claim construction (e.g., (“[c]ontext is central in claim construction”). Summary: Assignee Liqwid and exclusive licensee Olaplex (together … Continue reading
Travel Sentry, Inc. v. David A. Tropp / David A. Tropp v. Conair, et al.
Docket No. 2016-2386, -2387, -2714, -1025 REYNA, LINN, CHEN December 19, 2017 Brief Summary: DC grant of SJ for no direct infringement under § 271(a) vacated and remanded because, e.g., “[a] reasonable jury could conclude that [TS’s] activities do establish … Continue reading
Posted in Inducement to Infringe, Infringement
Leave a comment
Sanofi, et al. v. Watson Laboratories, Sandoz Inc.
Docket No. 2016-2722, -2726 PROST, WALLACH, TARANTO November 9, 2017 Brief summary: DC decision finding inducement to infringe based on proposed drug label, no obviousness in view of prior art clinical trial documents, or prosecution history estoppel affirmed. Summary: Sanofi … Continue reading
